InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Wednesday, 05/10/2017 7:24:50 AM

Wednesday, May 10, 2017 7:24:50 AM

Post# of 8022
Earnings were ugly. No doubt about that. Dispute with pharmacy was the new undisclosed problem. Probably the reason for the high short interest.


*Vericel Reports Q1 EPS $(0.31) vs $(0.14) Est., Sales $9.4M vs $14.4M Est.

But there is hope.

-- Increased MACI biopsies 17% in Q1 2017 compared to Q1 2016;
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News